3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
55
Myelodysplastic Syndromes
32
Leukemia
18
Leukemia, Myelomonocytic, Chronic
11
Congenital Abnormalities
5
Recurrence
4
Neoplasms
4
Melanoma
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Erythroblastic, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Anemia, Refractory
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Primary Myelofibrosis
1
Interventions
Dexamethasone
17
Melphalan
14
Bortezomib
10
Calcium Dobesilate
8
Filgrastim
6
Granulocyte Colony-Stimulating Factor
5
Cyclophosphamide
5
birtamimab
4
dexamethasone acetate
3
Whole-Body Irradiation
3
Thalidomide
3
Peripheral Blood Stem Cell Transplantation
3
Lenalidomide
3
fludarabine phosphate
2
daratumumab
2
Mycophenolic Acid
2
Etoposide
2
Doxycycline
2
Darbepoetin alfa
2
Cyclosporine
2
Busulfan
2
Blood Component Removal
2
pomalidomide
1
pegfilgrastim
1
ixazomib
1
isatuximab
1
ferrous sulfate
1
ferric gluconate
1
dexamethasone 21-phosphate
1
carfilzomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoglobulin Light-chain Amyloidosis
×
Decitabine
×
Clear all
No trials found.